IL17A and non-small cell lung carcinoma: This was confirmed by the reduced IFN-γ+, IL-4+, and IL-17+ T cells, together with increased IL-10-expressing T cells, upon NSCLC pre-coculture and subsequent activation (Fig. 1C, D).